Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain.
Public ClinicalTrials.gov record NCT00290901. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Six Week Double-Blind, Randomized, Multicenter Comparison Study of the Analgesic Effectiveness of Celecoxib 200 mg BID Compared to Tramadol Hydrochloride 50 mg QID in Subjects With Chronic Low Back Pain
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study investigates if Celebrex is as effective as tramadol hydrochloride (Ultram) for patients with chronic low back pain, when administered over a 6-week period.
Study identification
- NCT ID
- NCT00290901
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 754 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2006 (Type not available)
- Primary completion
- Dec 2006 (Actual)
- Completion
- Not listed
- Last update posted
- Mar 3, 2021
Started 2006
United States locations
- U.S. sites
- 53
- U.S. states
- 23
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Phoenix | Arizona | — | — |
| Pfizer Investigational Site | Scottsdale | Arizona | — | — |
| Pfizer Investigational Site | Tucson | Arizona | — | — |
| Pfizer Investigational Site | Little Rock | Arkansas | — | — |
| Pfizer Investigational Site | Anaheim | California | — | — |
| Pfizer Investigational Site | La Mesa | California | — | — |
| Pfizer Investigational Site | Long Beach | California | — | — |
| Pfizer Investigational Site | Oceanside | California | — | — |
| Pfizer Investigational Site | Paramount | California | — | — |
| Pfizer Investigational Site | Sacramento | California | — | — |
| Pfizer Investigational Site | San Francisco | California | — | — |
| Pfizer Investigational Site | San Luis Obispo | California | — | — |
| Pfizer Investigational Site | Tustin | California | — | — |
| Pfizer Investigational Site | Vista | California | — | — |
| Pfizer Investigational Site | Boulder | Colorado | — | — |
| Pfizer Investigational Site | Colorado Springs | Colorado | — | — |
| Pfizer Investigational Site | Denver | Colorado | — | — |
| Pfizer Investigational Site | Cos Cob | Connecticut | — | — |
| Pfizer Investigational Site | Washington D.C. | District of Columbia | — | — |
| Pfizer Investigational Site | Miami | Florida | — | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | — | — |
| Pfizer Investigational Site | West Palm Beach | Florida | — | — |
| Pfizer Investigational Site | Decatur | Georgia | — | — |
| Pfizer Investigational Site | Woodstock | Georgia | — | — |
| Pfizer Investigational Site | Libertyville | Illinois | — | — |
| Pfizer Investigational Site | Morton Grove | Illinois | — | — |
| Pfizer Investigational Site | Arkansas City | Kansas | — | — |
| Pfizer Investigational Site | Overland Park | Kansas | — | — |
| Pfizer Investigational Site | Wichita | Kansas | — | — |
| Pfizer Investigational Site | Madisonville | Kentucky | — | — |
| Pfizer Investigational Site | Baltimore | Maryland | — | — |
| Pfizer Investigational Site | Wheaton | Maryland | — | — |
| Pfizer Investigational Site | Jackson | Mississippi | — | — |
| Pfizer Investigational Site | Kansas City | Missouri | — | — |
| Pfizer Investigational Site | St Louis | Missouri | — | — |
| Pfizer Investigational Site | Omaha | Nebraska | — | — |
| Pfizer Investigational Site | Brooklyn | New York | — | — |
| Pfizer Investigational Site | New York | New York | — | — |
| Pfizer Investigational Site | Rochester | New York | — | — |
| Pfizer Investigational Site | Raleigh | North Carolina | — | — |
| Pfizer Investigational Site | Medford | Oregon | — | — |
| Pfizer Investigational Site | Portland | Oregon | — | — |
| Pfizer Investigational Site | Camp Hill | Pennsylvania | — | — |
| Pfizer Investigational Site | Duncansville | Pennsylvania | — | — |
| Pfizer Investigational Site | Charleston | South Carolina | — | — |
| Pfizer Investigational Site | Columbia | South Carolina | — | — |
| Pfizer Investigational Site | Johnson City | Tennessee | — | — |
| Pfizer Investigational Site | New Tazewell | Tennessee | — | — |
| Pfizer Investigational Site | Austin | Texas | — | — |
| Pfizer Investigational Site | San Angelo | Texas | — | — |
| Pfizer Investigational Site | San Antonio | Texas | — | — |
| Pfizer Investigational Site | Arlington | Virginia | — | — |
| Pfizer Investigational Site | Danville | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00290901, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 3, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00290901 live on ClinicalTrials.gov.